C M Shipman

2.4k total citations
31 papers, 2.0k citations indexed

About

C M Shipman is a scholar working on Oncology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C M Shipman has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 15 papers in Hematology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C M Shipman's work include Bone health and treatments (23 papers), Multiple Myeloma Research and Treatments (15 papers) and Radiopharmaceutical Chemistry and Applications (13 papers). C M Shipman is often cited by papers focused on Bone health and treatments (23 papers), Multiple Myeloma Research and Treatments (15 papers) and Radiopharmaceutical Chemistry and Applications (13 papers). C M Shipman collaborates with scholars based in United Kingdom, Belgium and United States. C M Shipman's co-authors include Peter I. Croucher, R.G.G. Russell, Michael J. Rogers, Robert E. Coleman, S. Jagdev, Karin Vanderkerken, Ingunn Holen, Ben Van Camp, M.H. Helfrich and J M Lippitt and has published in prestigious journals such as Blood, Cancer and British Journal of Cancer.

In The Last Decade

C M Shipman

30 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C M Shipman United Kingdom	14	1.6k	774	533	481	344	31	2.0k
Thomas Moehler Germany	25	739 0.5×	1.1k 1.4×	253 0.5×	1.4k 2.8×	185 0.5×	69	2.1k
Changpu Yu United States	12	674 0.4×	728 0.9×	279 0.5×	180 0.4×	128 0.4×	22	1.5k
María Eugenia Sarasquete Spain	26	608 0.4×	971 1.3×	70 0.1×	837 1.7×	174 0.5×	80	1.9k
Bei-Qing Pan China	12	566 0.4×	482 0.6×	85 0.2×	142 0.3×	202 0.6×	14	924
Hidekazu Segawa Japan	15	458 0.3×	317 0.4×	180 0.3×	233 0.5×	29 0.1×	20	985
Noemi Horvath Australia	20	978 0.6×	990 1.3×	85 0.2×	1.2k 2.5×	56 0.2×	60	1.7k
Manali Bendre United States	7	578 0.4×	551 0.7×	78 0.1×	89 0.2×	88 0.3×	8	990
Ivana Zavrski Germany	23	899 0.6×	938 1.2×	59 0.1×	888 1.8×	68 0.2×	34	1.6k
Kathy Rohrbach United States	5	941 0.6×	1.0k 1.3×	47 0.1×	51 0.1×	184 0.5×	7	1.5k
Inger Marie S. Dahl Norway	20	427 0.3×	696 0.9×	60 0.1×	1.1k 2.3×	45 0.1×	37	1.7k

Countries citing papers authored by C M Shipman

Since Specialization

Citations

This map shows the geographic impact of C M Shipman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C M Shipman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C M Shipman more than expected).

Fields of papers citing papers by C M Shipman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C M Shipman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C M Shipman. The network helps show where C M Shipman may publish in the future.

Co-authorship network of co-authors of C M Shipman

This figure shows the co-authorship network connecting the top 25 collaborators of C M Shipman. A scholar is included among the top collaborators of C M Shipman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C M Shipman. C M Shipman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bavia, Maria Emília, et al.. (2019). Environmental risk factors of leishmaniasis in Bahia State, Brazil using NASA Earth observation satellites. REVISTA DO INSTITUTO ADOLFO LUTZ. 78. 1–7.

2.

Edwards, Claire M., Sanyuan Sun, Rachel M. Locklin, et al.. (2006). LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis & Rheumatism. 54(5). 1451–1462. 78 indexed citations

3.

Roelofs, Anke J., et al.. (2006). Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S‐phase arrest, in human myeloma cells. International Journal of Cancer. 119(6). 1254–1261. 53 indexed citations

4.

Oyajobi, Babatunde O., Abhishek Gupta, Cyrilla H. Wideman, et al.. (2005). Dkk1 modulates osteoclastogenesis and bone resorption: Implications for myeloma bone disease.. Journal of Bone and Mineral Research. 20. 2 indexed citations

5.

Locklin, Rachel M., Ermanno Federici, Peter I. Croucher, R.G.G. Russell, & C M Shipman. (2005). Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2. Journal of Bone and Mineral Research. 20. 1307–1307. 1 indexed citations

6.

Edwards, Jeffrey D., et al.. (2004). LIGHT (TNFSF14), a novel mediator of normal and pathological bone resorption.. Journal of Bone and Mineral Research. 19. 1 indexed citations

7.

Edwards, et al.. (2004). Light, a TNF-superfamily member, induces osteoclast formation in vitro; A novel mediator of bone resorption?. Journal of Bone and Mineral Research. 19. 1051–1051. 1 indexed citations

8.

Croucher, Peter I., C M Shipman, Ben Van Camp, & Karin Vanderkerken. (2003). Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease. Cancer. 97(S3). 818–824. 27 indexed citations

9.

Leenheer, Evy De, Karin Vanderkerken, Marleen Bâkkus, et al.. (2002). Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.. Blood. 100. 2 indexed citations

10.

Raeve, Hendrik De, Mark Perry, C M Shipman, et al.. (2002). Zoledronic acid prevents the development of osteolytic bone disease and increases survival in a murine model of multiple myeloma. Bone. 30. 3 indexed citations

11.

Croucher, Peter I., C M Shipman, Mark Perry, et al.. (2001). Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. Bone. 28(5). 1 indexed citations

12.

Jagdev, S., et al.. (2001). The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. British Journal of Cancer. 84(8). 1126–1134. 281 indexed citations

13.

Croucher, Peter I., C M Shipman, Mark Perry, et al.. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma. Blood. 98. 6 indexed citations

14.

Russell, R.G.G., et al.. (2001). Clinical Disorders of Bone Resorption. Novartis Foundation symposium. 232. 251–271. 22 indexed citations

15.

Croucher, Peter I., C M Shipman, Mark Perry, et al.. (2000). Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.. Blood. 96(11). 1 indexed citations

16.

Shipman, C M, et al.. (2000). Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.. Journal of Bone and Mineral Research. 15. 1217–1217. 2 indexed citations

17.

Shipman, C M, Ingunn Holen, J M Lippitt, Elisabeth Vandenberghe, & Peter I. Croucher. (2000). Tumour cells isolated from patients with multiple myeloma express the critical osteoclastogenic factor, RANKL.. Blood. 96. 13 indexed citations

18.

Shipman, C M, Karin Vanderkerken, Michael J. Rogers, et al.. (2000). The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma. British Journal of Haematology. 111(1). 283–286. 25 indexed citations

19.

Shipman, C M, Karin Vanderkerken, Michael J. Rogers, et al.. (2000). The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma. British Journal of Haematology. 111(1). 283–286. 12 indexed citations

20.

Shipman, C M, et al.. (1997). Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity. British Journal of Haematology. 98(3). 665–672. 350 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact